Search

everythinglearnresearchcommunity

for

Search:↓

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

New alopecia treatments aim for better results and fewer side effects.

Apigenin may help promote hair growth and could treat hair loss.

Finasteride can cause one-sided breast enlargement, which disappears after stopping the drug.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Several new treatments for different types of hair loss show promise in improving patient quality of life.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Anifrolumab improves quality of life and reduces steroid use in SLE patients.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.